A novel MYH9 mutation in a patient with MYH9 disorders and platelet size-specific effect of romiplostim on macrothrombocytopenia
- 9 June 2015
- journal article
- Published by Springer Science and Business Media LLC in Annals of Hematology
- Vol. 94 (9), 1599-1600
- https://doi.org/10.1007/s00277-015-2416-x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Myosin-II repression favors pre/proplatelets but shear activation generates platelets and fails in macrothrombocytopeniaBlood, 2015
- Mutation spectrum and genotype‐phenotype correlations in a large French cohort of MYH9‐Related DisordersMolecular Genetics & Genomic Medicine, 2014
- MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype CorrelationsHuman Mutation, 2013
- Short-term eltrombopag for surgical preparation of a patient with inherited thrombocytopenia deriving from MYH9 mutationThrombosis and Haemostasis, 2012
- A patient with Fechtner syndrome successfully treated with romiplostimThrombosis and Haemostasis, 2012
- Recent advances in the understanding and management of MYH9‐related inherited thrombocytopeniasBritish Journal of Haematology, 2011
- Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutationsBlood, 2010
- Advances in the understanding of MYH9 disordersCurrent Opinion in Hematology, 2010